Filing Details

Accession Number:
0001209191-11-016053
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-07 18:53:08
Reporting Period:
2011-03-03
Filing Date:
2011-03-07
Accepted Time:
2011-03-07 18:53:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100962 Endo Pharmaceuticals Holdings Inc ENDP Pharmaceutical Preparations (2834) 134022871
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1455549 J Edward Sweeney C/O Endo Pharmaceuticals Holdings Inc.
100 Endo Boulevard
Chadds Ford PA 19317
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value, $.01 Per Share Acquisiton 2011-03-03 1,292 $16.47 1,292 No 4 M Direct
Common Stock, Par Value, $.01 Per Share Disposition 2011-03-03 1,292 $36.00 0 No 4 S Direct
Common Stock, Par Value, $.01 Per Share Acquisiton 2011-03-03 6,339 $28.61 6,339 No 4 M Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2011-03-03 6,339 $36.25 0 No 4 S Direct
Common Stock, Par Value, $0.01 Per Share Acquisiton 2011-03-03 4,612 $30.55 4,612 No 4 M Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2011-03-03 4,612 $36.25 0 No 4 S Direct
Common Stock, Par Value, $0.01 Per Share Acquisiton 2011-03-03 5,068 $25.19 5,068 No 4 M Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2011-03-03 5,068 $36.00 0 No 4 S Direct
Common Stock, Par Value, $0.01 Per Share Acquisiton 2011-03-03 5,760 $19.93 5,760 No 4 M Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2011-03-03 5,760 $36.00 0 No 4 S Direct
Common Stock, Par Value, $0.01 Per Share Acquisiton 2011-03-03 3,319 $20.61 3,319 No 4 M Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2011-03-03 3,319 $36.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2000 Stock Incentive Plan Options Disposition 2011-03-03 1,292 $0.00 1,292 $16.47
Common Stock 2004 Stock Incentive Plan Options Disposition 2011-03-03 6,339 $0.00 6,339 $28.61
Common Stock 2000 Stock Incentive Plan Options Disposition 2011-03-03 4,612 $0.00 4,612 $30.55
Common Stock 2007 Stock Incentive Plan Options Disposition 2011-03-03 5,068 $0.00 5,068 $25.19
Common Stock 2007 Stock Incentive Plan Options Disposition 2011-03-03 5,760 $0.00 5,760 $19.93
Common Stock 2007 Stock Incentive Plan Options Disposition 2011-03-03 3,319 $0.00 3,319 $20.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-08-11 No 4 M Direct
0 2016-02-14 No 4 M Direct
0 2017-02-21 No 4 M Direct
1,689 2018-02-21 No 4 M Direct
5,760 2019-02-26 No 4 M Direct
9,957 2020-02-19 No 4 M Direct
Footnotes
  1. This represents the average price that Mr. Sweeney's common shares were sold at on March 3, 2011.
  2. Mr. Sweeney's stock options that were granted under the 2000 Stock Incentive Plan on August 11, 2004 were exercisable 25% per year on each of August 11, 2005, August 11, 2006, August 11, 2007 and August 11, 2008. The 1,292 stock options that were exercised now are those that remained exercisable from Mr. Sweeney's original grant of 2,586 stock options.
  3. These securities were granted to Mr. Sweeney in consideration of his services as the Principal Accounting Officer of Endo Pharmaceuticals Holdings Inc.
  4. Mr. Sweeney's stock options that were granted under the 2004 Stock Incentive Plan on February 14, 2006 were exercisable 25% per year on each of February 14, 2007, February 14, 2008, February 14, 2009 and February 14, 2010. The 6,339 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 6,339 stock options.
  5. Mr. Sweeney's stock options that were granted under the 2000 Stock Incentive Plan on February 21, 2007 were exercisable 25% per year on each of February 21, 2008, February 21, 2009, February 21, 2010 and February 21, 2011. The 4,612 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 4,612 stock options, including those that became exercisable on February 21, 2011.
  6. Mr. Sweeney's stock options that were granted under the 2007 Stock Incentive Plan on February 21, 2008 are generally exercisable 25% per year on each of February 21, 2009, February 21, 2010, February 21, 2011 and February 21, 2012. The 5,068 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 6,757 stock options, including those that became exercisable on February 21, 2011.
  7. Mr. Sweeney's stock options that were granted under the 2007 Stock Incentive Plan on February 26, 2009 are generally exercisable 25% per year on each of February 26, 2010, February 26, 2011, February 26, 2012 and February 26, 2013. The 5,760 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 11,520 stock options, including those that became exercisable on February 26, 2011.
  8. Mr. Sweeney's stock options that were granted under the 2007 Stock Incentive Plan on February 19, 2010 are generally exercisable 25% per year on each of February 19, 2011, February 19, 2012, February 19, 2013 and February 19, 2014. The 3,319 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 13,276 stock options and are those shares that became exercisable on February 19, 2011.